Source: Eur Respir Rev 2008; 17: 130-137
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chambers R. C.. Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling. Eur Respir Rev 2008; 17: 130-137

Member's Comments

No comment yet.

Related content which might interest you: Coagulation in lung fibrosis: multiple pathways leading to fibroblast activation Source: Annual Congress 2012 - PG11 Pulmonary fibrosis Year: 2012 Role of coagulation cascade proteases and lung repair and fibrosis Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease Year: 2003 Role of coagulation cascade proteases in lung repair and fibrosis Source: Eur Respir J 2003; 22: 33S-35S Year: 2003 Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Protease-activated receptor-2 triggers epithelial to mesenchymal transition: Potential relevance in pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 The epidermal growth factor receptor mediates allergic airway remodelling in the rat Source: Eur Respir J 2008; 32: 1213-1223 Year: 2008 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation Source: Eur Respir J 2007; 30: 423-428 Year: 2007 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Apoptosis in lung injury and fibrosis Source: Eur Respir J 2008; 32: 1631-1638 Year: 2008 Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway Source: Eur Respir J 2008; 31: 523-531 Year: 2008 Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013